Other ingredients: Gelatin, microcrystalline cellulose
What to do instead: MHRA-approved options Two GLP-1 weight-loss medications are currently approved by the MHRA and recommended by NICE for use in eligible adults: Mounjaro (tirzepatide) and Wegovy (semaglutide)
Draw 40 units
Glucagon receptor activation drives energy expenditure through thermogenesis, promotes hepatic fat oxidation, and enhances lipolysis in ways that GLP-1 activation alone simply cannot achieve
They enhance glucose-induced insulin release, inhibit glucagon secretion, and notably, foster substantial weight loss, potentially reducing insulin resistance
We complement medical weight loss with practical guidance related to nutrition, physical activity, and sustainable daily habits